FDA Approves Revolutionary Liver Disease Drug Approved: A New Dawn for Millions Suffering from NASH
The U.S. Food and Drug Administration (FDA) recently approved Rezdiffra (resmetirom), a groundbreaking treatment for adults with non-cirrhotic non-alcoholic steatohepatitis (NASH) accompanied by moderate to advanced liver scarring, or fibrosis.…